YM BioSciences(加拿大)

YM BioSciences

加拿大YMBioScienceswww.ymbiosciences.com是為全球病人一家從事癌癥藥物及急救藥品研發(fā)及商業(yè)化的公司。2012年Gilead收購YMBioSciences YMBioSciencesisalifesciencesproductdevelopmentcompanythatidentifiesandadvancesadiverseportfolioofpromising cancer-relatedproductsatvariousstagesofdevelopment.YMhasprovenregulatoryandclinicaltrialexpertiseandadiversifiedbusinessmodeldesignedtoreduceriskwhileadvancingclinicalproductstowardinternationalapproval,marketingandcommercialization.TheCompanyiscurrentlyadvancingtwolate-stageproducts:Nimotuzumab:anEGFR-targetingAffinity-OptimizedAntibody™indevelopmentworldwide,targetingmultipletumortypesprimarilyincombinationwithradiationandchemoradiation,andapprovedformarketinginover12countries.AeroLEF®:aproprietary,inhaled-deliverycompositionoffentanylindevelopmentforthetreatmentofmoderatetosevereacutepain.